期刊文献+

5α-氯-6β-羟基-雄甾-3,17-二酮的合成

The Synthesis of 5α-Chloro-6β-hydroxy-androst-3,17-dione
下载PDF
导出
摘要 以4-雄烯二酮为原料,经羰基保护、双键卤羟化、水解脱保护三步反应合成了5α-氯-6β-羟基-雄甾-3,17-二酮。讨论了保护试剂、催化剂、卤羟化试剂、反应温度等对实验结果的影响,得出了较佳工艺条件,三步总收率达到88%。 Using 4-androstenedione as raw material, 5α-chloro-6β-hydroxy-androst-3,17-dione was synthesized via carbonyl protection, halogen hydroxylation of double bound and hydrolysis deprotection. The effect of protecting agent, catalyst, halogen hydroxylation agent and temperature were discussed. A better technological condition was obtained with the total yields of 88%.
出处 《浙江化工》 CAS 2014年第11期16-18,共3页 Zhejiang Chemical Industry
关键词 4-雄烯二酮 5α-氯-6β-羟基-雄甾-3 17-二酮 中间体 4-androstenedione 5α-chloro-6β-hydroxy-androst-3,17-dion intermediate
  • 相关文献

参考文献9

  • 1Murphy A A, Kettl L M, Morales A J, et al. Regression of uterine leiomyomata in response to antiprogesterone RU486 [J]. Chin. Endocrinol. Metab., 1993, 76: 513-517.
  • 2Gao Y, Short R V. Fertility control in laoboratory rats and mice after feeding with the antgestagn RU486[J]. Journal of reproducetion and fertility, 1994, 101: 477-481.
  • 3Khoo M L, Asa S L, Witterick I J, et al. Thyroid calcifica- tion and its association with thyroid carcinoma[J]. Heda. Neck., 2002, 24(7): 651-655.
  • 4周青松.黄体初期短程应用米非司酮治疗子宫内膜异位症37例疗效分析[J].中国实用妇科与产科杂志,2006,22(9):702-703. 被引量:15
  • 5Messinger J, Thole H H. Novel C 18 modified retrosteroids as progesterone receptor modulator compounds: WO, 2007039544 AI[P].2007-04-12.
  • 6Herzog H L, Jevnik M A, Tully M E, et al. Cylic ketals of 4-androstene- 3,17-dione[J]. J. Am. Chem. Soe., 1953, 75: 1481-1482.
  • 7Stephan E, Brossat M, Lecomte V, et al. Synthesis of the 1 1β-hydroxymethyl-androst- 4-en-3,17-dione[J]. Tetra- hedron., 2006, 62: 3052-3055.
  • 8金灿,徐寅,金炜华,苏为科.米非司酮关键中间体合成工艺改进[J].浙江化工,2013,44(12):8-9. 被引量:1
  • 9Mukawa F S. XVII. The oxidation of hydroxysteroids with isocyanuric chloride[J] . Nippon Kagaku Zasshi, 1957, 78: 450-452.

二级参考文献18

  • 1牛玉铃,王金金,张凯.手术联合米非司酮治疗子宫内膜异位症的临床观察[J].中国实用医药,2007,2(15):91-93. 被引量:2
  • 2陈杰,潘晓玲.子宫内膜异位症的药物治疗进展[J].现代预防医学,2004,31(2):216-218. 被引量:17
  • 3刘英,王宇,李梅.小剂量米非司酮治疗子宫内膜异位症的临床观察[J].西南国防医药,2004,14(1):47-49. 被引量:16
  • 4张凤霞,郭思言.米非司酮临床应用新进展[J].华北煤炭医学院学报,2006,8(1):59-60. 被引量:4
  • 5Kettel LM,Murphy AA,Morales AJ,et al.Preliminary report on the treatment of endometriosis with low-dose mifepristone (RU 486)[J].Am J Obstet Gynecol,1998,178(6):1151-1156.
  • 6Jiang J,Wu RF,Wang ZH,et al.Effect of mifepristone on estrogen and progesterone receptors in human endometrial and endometriotic cells in vitro[J].Fertil Steril,2002,77 (5):995-1000.
  • 7Kettel LM,Murphy AA,Morales AJ,et al.Treatment of endometriosis with the antiprogesterone mifepristone (RU486)[J].Fertil Steril,1996,65(1):23-28.
  • 8Spitz IM,Grunberg SM,Chabbert-Buffet N,et al.Management of patients receiving long-term treatment with mifepristone[J].Fertil Steril,2005,84(6):1719-1726.
  • 9Nayak NR,Ghosh D,Sengupta J.Effect of luteal phase administration of mifepristone (RU486) and prostaglanding analogue or inhibitor on endometrium in the rhesus monkey[J].Hum Reprod,1998,13(4):1047-1056.
  • 10Croxatto HB,Salvatierra AM,Croxatto HD,et al.Effects of continuous treatment with low dose mifepristone throughout one menstrual cycle[J].Hum Reprod,1993,8(2):201-207.

共引文献14

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部